miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer
Authors
Keywords
miR-218, Survivin, Apoptosis, Drug resistance, Doxorubicin, Taxol
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 151, Issue 2, Pages 269-280
Publisher
Springer Nature
Online
2015-04-21
DOI
10.1007/s10549-015-3372-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery
- (2015) Jijin Gu et al. BIOMATERIALS
- The microRNA-218~Survivin axis regulates migration, invasion, and lymph node metastasis in cervical cancer
- (2015) Ryunosuke Kogo et al. Oncotarget
- HDAC 1/4-mediated silencing of microRNA-200b promotes chemoresistance in human lung adenocarcinoma cells
- (2015) Dong-Qin Chen et al. Oncotarget
- MicroRNA-218 is upregulated in gastric cancer after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy and increases chemosensitivity to cisplatin
- (2014) Xiang-Liang Zhang WORLD JOURNAL OF GASTROENTEROLOGY
- Reduced expression of circulating microRNA-218 in gastric cancer and correlation with tumor invasion and prognosis
- (2014) Shi-Yong Xin WORLD JOURNAL OF GASTROENTEROLOGY
- microRNA Control of Mouse and Human Pluripotent Stem Cell Behavior
- (2013) Tobias S. Greve et al. Annual Review of Cell and Developmental Biology
- MicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN
- (2013) Fang Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Sorcin silencing inhibits epithelial-to-mesenchymal transition and suppresses breast cancer metastasis in vivo
- (2013) Yunhui Hu et al. BREAST CANCER RESEARCH AND TREATMENT
- Inhibition of sorcin reverses multidrug resistance of K562/A02 cells and MCF-7/A02 cells via regulating apoptosis-related proteins
- (2013) Yunhui Hu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The miR-106b∼25 cluster promotes bypass of doxorubicin-induced senescence and increase in motility and invasion by targeting the E-cadherin transcriptional activator EP300
- (2013) Y Zhou et al. CELL DEATH AND DIFFERENTIATION
- MicroRNA-31 Sensitizes Human Breast Cells to Apoptosis by Direct Targeting of Protein Kinase C ϵ (PKCϵ)
- (2013) Cindy Körner et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Loss of p53 and altered miR15-a/16-1→MCL-1 pathway in CLL: insights from TCL1-Tg:p53 −/− mouse model and primary human leukemia cells
- (2013) J Liu et al. LEUKEMIA
- MicroRNA-497 increases apoptosis in MYCN amplified neuroblastoma cells by targeting the key cell cycle regulator WEE1
- (2013) Laura Creevey et al. Molecular Cancer
- miR-7 and miR-218 epigenetically control tumor suppressor genes RASSF1A and Claudin-6 by targeting HoxB3 in breast cancer
- (2012) Qiaoyan Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Loss of O6-methylguanine-DNA methyltransferase confers collateral sensitivity to carmustine in topoisomerase II-mediated doxorubicin resistant triple negative breast cancer cells
- (2012) Selina Raguz et al. BIOCHEMICAL PHARMACOLOGY
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MiR-218 Impairs Tumor Growth and Increases Chemo-Sensitivity to Cisplatin in Cervical Cancer
- (2012) Jiarui Li et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- α2β1 Integrin Promotes Chemoresistance against Doxorubicin in Cancer Cells through Extracellular Signal-regulated Kinase (ERK)
- (2012) Dalila Naci et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Survivin Signaling in Clinical Oncology: A Multifaceted Dragon
- (2012) Jagat R. Kanwar et al. MEDICINAL RESEARCH REVIEWS
- Cancer drug's survivin suppression called into question
- (2012) David Holmes NATURE MEDICINE
- miR-218 Suppresses Nasopharyngeal Cancer Progression through Downregulation of Survivin and the SLIT2-ROBO1 Pathway
- (2011) N. M. Alajez et al. CANCER RESEARCH
- The Tumor Suppressive MicroRNA miR-218 Targets the mTOR Component Rictor and Inhibits AKT Phosphorylation in Oral Cancer
- (2011) A. Uesugi et al. CANCER RESEARCH
- Chromosomal Instability Confers Intrinsic Multidrug Resistance
- (2011) A. J. X. Lee et al. CANCER RESEARCH
- Reduced miR-128 in Breast Tumor-Initiating Cells Induces Chemotherapeutic Resistance via Bmi-1 and ABCC5
- (2011) Y. Zhu et al. CLINICAL CANCER RESEARCH
- Regulation of miR-19 to Breast Cancer Chemoresistance Through Targeting PTEN
- (2011) Zhongxing Liang et al. PHARMACEUTICAL RESEARCH
- Thrombocytopenia in the Intensive Care Unit Patient
- (2011) A. Greinacher et al. Hematology-American Society of Hematology Education Program
- Paxillin Predicts Survival and Relapse in Non-Small Cell Lung Cancer by MicroRNA-218 Targeting
- (2010) D.-W. Wu et al. CANCER RESEARCH
- miRNAs in human cancer
- (2010) Thalia A Farazi et al. JOURNAL OF PATHOLOGY
- Elevated expression of erbB3 confers paclitaxel resistance in erbB2-overexpressing breast cancer cells via upregulation of Survivin
- (2010) S Wang et al. ONCOGENE
- DNA methylation inhibits p53-mediated survivin repression
- (2009) N H Nabilsi et al. ONCOGENE
- Significance of P-glycoprotein, p53, and survivin expression in renal cell carcinoma
- (2009) Firat Baytekin et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Targeting survivin in cancer therapy
- (2008) Marzia Pennati et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1
- (2008) Tyler E. Miller et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now